Fingerprint
Dive into the research topics of 'Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
for the Study 309–KEYNOTE-775 Investigators
Research output: Contribution to journal › Article › peer-review
361
Scopus
citations